John G. Armstrong

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Dipexium Pharmaceuticals Ireland Ltd. provides professional, scientific, and technical services.

Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland.

Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland.

Part of Zoetis, Inc., BioNua Ltd. is a company headquartered in Ireland that develops and manufactures biopharmaceuticals in the field of veterinary biologic therapies.

Part of Advanced Medical Solutions Group Plc, Connexicon Medical Ltd. is an Irish company that manufactures and wholesales tissue adhesives and sealants. The company is based in Dublin, Ireland. The company was founded by Padraig Leamy. Padraig Leamy has been the CEO since incorporation. Connexicon Medical was acquired by Advanced Medical Solutions Group Plc on February 01, 2023 for $27.15 million.

Part of Baxter International, Inc., Baxter Healthcare Ltd. is a company based in Newbury, UK. Baxter Healthcare Ltd. helps maximize safety, streamline processes, and build cost efficiency throughout the hospital, from the pharmacy to the bedside. The British company was founded in 1948. José E. Almeida has been the CEO of the company since 2016.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Academia, Inc. develops and provides social sharing platform for academic researchers. Its platform enables researchers to share their research, monitor deep analytics, and track the research of academics they follow. The company was founded by Richard Price in September 2008 and is headquartered in San Francisco, CA.

Sicon Ltd. operates as a holding company with interests in construction businesses. The company is headquartered in Dublin, Ireland.

The SISK Group engages in the construction, distribution, manufacturing, and property business. The company was founded by John Sisk in 1859 and is headquartered in Dublin, Ireland.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia.

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA.

The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.

Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden.

Part of EKF Diagnostics Holdings Plc, Argutus Medical Ltd. develops and manufactures novel organ injury test and urinary biomarkers for the healthcare industry. The company is based in Dublin, Ireland. The Irish company was founded by Cormac G. Kilty. Argutus Medical was acquired by EKF Diagnostics Holdings Plc on December 02, 2010 for $3.67 million.

Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom.

CryptoMedix, Inc. operates as a biotechnology company, The company was founded in 2013 and is headquartered in Harpswell, ME.

Turbine Simulated Cell Technologies Ltd. is a British company that leverages AI technology to understand oncology patients with simulated cells. The company is based in London, UK. and has subsidiaries in Hungary. The company was founded in 2019 by Szabolcs Nagy, Ivan Fekete, Daniel Veres, Kristof Zsolt Szalay. Szabolcs Nagy has been the CEO since 2019.

Part of DiaSorin SpA, DiaSorin Ireland Ltd. develops, manufactures, and sells leading diagnostic tests for the identification of diseases and important life science products. The company is based in Blackrock, Ireland. The CEO of the Irish company is Cormac G. Kilty. DiaSorin Ireland was acquired by DiaSorin SpA on July 09, 2008 for $39.20 million.